Downs Christopher Insider Trades

Insider Trading History

Track insider trading activity for Downs Christopher. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $22.1k 4,881 shares
Last Trade
Nov 17, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$32.7k 4,881 shares
$6.70
$4.52
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $1.09k 241 shares
Last Trade
Apr 08, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$538M 80,000 shares
$6,720.00
$4.52
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $730k 161,572 shares
Last Trade
Feb 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.01B 133,332 shares
$7,575.00
$4.52
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $468k 103,438 shares
Last Trade
Feb 01, 2024 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$505M 66,666 shares
$7,575.00
$4.52
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $166k 36,772 shares
Last Trade
Aug 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.41B 27,000 shares
$52,200.00
$4.52
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $128k 28,248 shares
Last Trade
Apr 28, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.6M 521 shares
$45,300.00
$4.52
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $44.2k 9,772 shares
Last Trade
Apr 28, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.6M 521 shares
$45,300.00
$4.52
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $41.8k 9,251 shares
Last Trade
Apr 17, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$256M 3,100 shares
$82,500.00
$4.52
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $130k 28,768 shares
Last Trade
Mar 29, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$181M 6,067 shares
$29,886.00
$4.52
EBET
EBET EBET
Director
Holding Value $0.63 6,300 shares
Last Trade
Feb 09, 2023 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$115k 6,300 shares
$18.30
$0.00
EBET
EBET EBET
Director
Holding Value $7.5 75,000 shares
Last Trade
Feb 09, 2023 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$115k 6,300 shares
$18.30
$0.00
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $3.08M 681,000 shares
Last Trade
Apr 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$75.2B 250,000 shares
$300,600.00
$4.52
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $834k 184,500 shares
Last Trade
Mar 11, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10B 33,000 shares
$303,120.00
$4.52
EBET
EBET EBET
Director
Holding Value $8.13 81,300 shares
Last Trade
Feb 09, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.25M 6,300 shares
$357.90
$0.00
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $685k 151,500 shares
Last Trade
Dec 06, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.23B 5,000 shares
$846,000.00
$4.52
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $662k 146,500 shares
Last Trade
Nov 19, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$4.62B 4,500 shares
$1,026,000.00
$4.52
EBET
EBET EBET
Director
Holding Value $0 0 shares
Last Trade
Apr 14, 2021 Sale
No data
No data
$0.00
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $1.95M 431,000 shares
Last Trade
Feb 05, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$396B 131,000 shares
$3,024,000.00
$4.52
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $642k 142,000 shares
Last Trade
Aug 24, 2020 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$276B 142,000 shares
$1,944,000.00
$4.52
Cns Pharmaceuticals
Cns Pharmaceuticals CNSP
Chief Financial Officer
Holding Value $1.36M 300,000 shares
Last Trade
Nov 13, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.1T 300,000 shares
$3,672,000.00
$4.52

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up